BIORQ.US Biora Therapeutics, Inc.

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Nov 14, 2026
0.0001 0.2200
Market cap
USD 452.00
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.

Is BIORQ.US undervalued?

Graham number

The Graham number of Biora Therapeutics, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Biora Therapeutics, Inc. fundamental analysis

No fundamental analysis for Biora Therapeutics, Inc. yet.

Biora Therapeutics, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Biora Therapeutics, Inc.

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The comp…

Full company profile